Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine triphosphate (**ATP**) is a nucleotide composed of adenine, ribose sugar, and three phosphate groups. It serves as the universal **energy carrier** in all living cells by capturing chemical energy from food breakdown and releasing it to power essential cellular processes such as biosynthesis, muscle contraction, active transport across membranes, signal transduction via phosphorylation reactions by kinases, neurotransmission through purinergic receptors in the nervous system, regulation of blood flow, inflammatory responses, DNA/RNA synthesis, cell division, motility/exocytosis/endocytosis. Intracellular ATP concentration reflects mitochondrial function; its depletion or dysregulation underlies many pathological states including metabolic disorders and neurodegeneration. While crucial for life processes at the molecular level—and measurable as a biomarker—intracellular ATP itself is not considered a classical druggable target like enzymes or receptors but rather an essential metabolite whose homeostasis supports all aspects of cell biology[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine triphosphate (ATP).